Badrinath Jagannath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Badrinath Jagannath has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alican Özkan
Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA
1 shared publication - Arash Naziripour
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02215, USA
1 shared publication - Donald Elliot Ingber
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA
1 shared publication - Henrik Bengtsson
Novo Nordisk A/S, 2880 Bagsværd, Denmark
1 shared publication - Nandhinee Radha Shanmugam
Wyss Institute for Biologically Inspired Engineering Harvard University Boston Massachusetts 02115 USA
1 shared publication - Pawan Jolly
Wyss Institute for Biologically Inspired Engineering Harvard University Boston Massachusetts 02115 USA
1 shared publication
Latest Publications
- Open Access
- 6 March 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (3) , 171
An Antimicrobial and Antifibrotic Coating for Implantable Biosensors
Biofouling and foreign body responses have deleterious effects on the functionality and longevity of implantable biosensors, seriously impeding their implementation for long-term monitoring. Here, we describe a nanocomposite coating composed of a cross-linked lattice of bovine serum albumin and pentaamine-functionalized reduced graphene that is covalently coupled to antibody ligands for analyte detection as well as antibiotic drugs (gentamicin or ceftriaxone), which actively combats biofouling while retaining high electroconductivity and excellent electrochemical immunosensor behavior. Sensors overlaid with this coating inhibit the proliferation of Pseudomonas aeruginosa bacteria and adhesion of primary human fibroblasts while not having any significant effects on fibroblast viability or on the immune function of primary human monocytes. Under these conditions, the sensor maintains its electrochemical stability for at least 3 weeks after exposure to soluble proteins that interfere with the activity of uncoated sensors. Proof-of-concept for the coating’s applicability is demonstrated by integrating the antimicrobial coating within an immunosensor and demonstrating the detection of cytokines in both culture medium and complex human plasma. This new coating technology holds the potential to substantially increase the lifespan of implanted biosensors and widen their application areas, potentially enabling continuous monitoring of analytes in complex biofluids for weeks in vivo.
- 6 March 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (3) , 171
Open AccessAn Antimicrobial and Antifibrotic Coating for Implantable Biosensors
Biofouling and foreign body responses have deleterious effects on the functionality and longevity of implantable biosensors, seriously impeding their implementation for long-term monitoring. Here, we describe a nanocomposite coating composed of a cross-linked lattice of bovine serum albumin and pentaamine-functionalized reduced graphene that is covalently coupled to antibody ligands for analyte detection as well as antibiotic drugs (gentamicin or ceftriaxone), which actively combats biofouling while retaining high electroconductivity and excellent electrochemical immunosensor behavior. Sensors overlaid with this coating inhibit the proliferation of Pseudomonas aeruginosa bacteria and adhesion of primary human fibroblasts while not having any significant effects on fibroblast viability or on the immune function of primary human monocytes. Under these conditions, the sensor maintains its electrochemical stability for at least 3 weeks after exposure to soluble proteins that interfere with the activity of uncoated sensors. Proof-of-concept for the coating’s applicability is demonstrated by integrating the antimicrobial coating within an immunosensor and demonstrating the detection of cytokines in both culture medium and complex human plasma. This new coating technology holds the potential to substantially increase the lifespan of implanted biosensors and widen their application areas, potentially enabling continuous monitoring of analytes in complex biofluids for weeks in vivo.